FDA review panel gives thumbs up to Norplant.
D000569:Americas; D003257:Consumer Product Safety; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D005193:Family Planning Services; D006077:Government Agencies; D019359:Knowledge; D016912:Levonorgestrel; D009656:North America; D009938:Organizations; D014481:United States; D014486:United States Food and Drug Administration; D014492:United States Public Health Service
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D016912:Levonorgestrel
Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Implants; Contraceptive Methods; Developed Countries; Family Planning; Government Agencies; Knowledge; Levonorgestrel; North America; Northern America; Organizations; Product Approval; United States; Usfda; Usphs